InvestorsHub Logo
Followers 0
Posts 230
Boards Moderated 0
Alias Born 08/16/2009

Re: None

Wednesday, 07/31/2013 7:15:22 AM

Wednesday, July 31, 2013 7:15:22 AM

Post# of 18305
From NEO:
"Work also continues on our new plasma and urine-based, NeoSCORETM prostate cancer test. There are two goals for this test, to diagnose the presence of cancer in patients with BPH (benign prostatic hyperplasia), and to distinguish high-grade from low-grade prostate cancer in patients with prostate cancer. We are excited about the potential for this test and currently expect to launch it in the first half of 2014."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HDVY News